Beranda › Gagal Jantung › Massachusetts
Uji klinis Gagal Jantung di Massachusetts
45 studi untuk Gagal Jantung mencari peserta di lokasi di Massachusetts.
Kota di Massachusetts
Teks studi resmi (Bahasa Inggris)
ELEVATE-HFpEF Clinical Study
- Tufts Medical Center, Boston
Menerima peserta
Usia 40 ke atas · Semua jenis kelamin · Diperbarui 2 Okt 2026 · NCT06678841Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With Heart Failure and Impaired Kidney Function
- Research Site, Boston
- Research Site, Worcester
Menerima pesertaFase 3
Usia 18 hingga 130 · Semua jenis kelamin · Diperbarui 2 Okt 2026 · NCT06307652A Randomized Placebo-procedure Controlled Trial of the Enhancor System (PULmonary Artery Denervation) to Evaluate Safety and Efficacy in Patients With Combined Pre- and Post-capillary Pulmonary Hypertension Associated With Left Heart Disease
- Boston Medical Center, Boston
Menerima peserta
Usia 18 hingga 85 · Semua jenis kelamin · Diperbarui 1 Okt 2026 · NCT07214376Myocardial Mechanisms in Heart Failure With Preserved Ejection Fraction
- Mass General Brigham, Boston
Menerima pesertaStudi observasionalSukarelawan sehat diterima
Usia 30 ke atas · Semua jenis kelamin · Diperbarui 29 Sep 2026 · NCT06517186HeartShare: Combining Omics, Deep Phenotyping, and Electronic Health Records for Heart Failure Subtypes and Treatment Targets
- Mass General Brigham, Boston
Menerima pesertaStudi observasionalSukarelawan sehat diterima
Usia 30 ke atas · Semua jenis kelamin · Diperbarui 29 Sep 2026 · NCT05873634A Study to Investigate CV Outcomes With Elecoglipron Compared With Placebo in Adult Participants With HFpEF or HFmrEF
- Research Site, Boston
- Research Site, Boston
- Research Site, New Bedford
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 28 Sep 2026 · NCT07761117Study With Omecamtiv Mecarbil (CK-1827452) to Treat Chronic Heart Failure With Severely Reduced Ejection Fraction
- Tufts Medical Center, Boston
Menerima pesertaFase 3
Usia 18 hingga 85 · Semua jenis kelamin · Diperbarui 24 Sep 2026 · NCT06736574Alleviant ALLAY-HFrEF Study
- Tufts Medical Center, Boston
- Brigham and Women's Hospital, Boston
- Boston Medical Center, Boston
Menerima peserta
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 16 Sep 2026 · NCT06812533Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With Dapagliflozin
- Research Site, Boston
- Research Site, Roslindale
Menerima pesertaFase 3
Usia 40 ke atas · Semua jenis kelamin · Diperbarui 15 Sep 2026 · NCT06677060A Study to Determine the Efficacy and Safety of Finerenone on Morbidity and Mortality Among Hospitalized Heart Failure Patients
- Boston, MA Investigative Stie 10087, Boston
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 10 Sep 2026 · NCT06008197Investigation of the BrioVAD System for the Treatment of Left Ventricular Heart Failure
- Tufts Medical Center, Boston
- Massachusetts General Hospital, Boston
Menerima peserta
Usia 18 hingga 100 · Semua jenis kelamin · Diperbarui 9 Sep 2026 · NCT06310031Safety and Effectiveness of Left Bundle Branch Area Pacing Versus Conventional Cardiac Resynchronization Therapy in Heart Failure
- Southcoast Physicians Group, Fall River
Menerima peserta
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 4 Sep 2026 · NCT07069738Prevalence and Prediction of ATTR in Ambulatory Patients With HFpEF
- Massachusetts General Hospital, Boston
Menerima peserta
Usia 65 ke atas · Semua jenis kelamin · Diperbarui 1 Sep 2026 · NCT05577819Targeted Artificial Intelligence Language mOdel Recommendations for Heart Failure (TAILOR-HF)
- Mass General Brigham, Boston
Menerima peserta
Usia 18 hingga 85 · Semua jenis kelamin · Diperbarui 31 Agu 2026 · NCT07337577Biomechanical Precision Medicine Registry for Patients With and Without Heart Failure
- Massachusetts General Hospital, Boston
Menerima pesertaStudi observasionalSukarelawan sehat diterima
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 31 Agu 2026 · NCT03480633Efficacy, Safety, and Pharmacokinetics of Vericiguat in Pediatric Participants With Heart Failure Due to Left Ventricular Systolic Dysfunction (MK-1242-036)
- Boston Children's Hospital ( Site 0035), Boston
Menerima pesertaFase 2/3
29 Days – 17 Years · Semua jenis kelamin · Diperbarui 28 Agu 2026 · NCT05714085AMBER-HFpEF: Assessment of CK-4021586 in a Multi-Center, Blinded Evaluation of Safety and Tolerability Results in HFpEF
- Massachusetts General Hospital, Boston
Menerima pesertaFase 2
Usia 40 hingga 85 · Semua jenis kelamin · Diperbarui 27 Agu 2026 · NCT06793371Retinal Fundus Imaging and OCT Imaging for Ocular Detection of ATTR-CM
- Research Site, Boston
Menerima pesertaStudi observasional
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 26 Agu 2026 · NCT07690436Product Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy Products
- Boston
Menerima pesertaStudi observasional
Semua usia · Semua jenis kelamin · Diperbarui 20 Agu 2026 · NCT00271180A Prospective Registry Study to Assess Real-world Patient Characteristics, Treatment Patterns, and Longitudinal Outcomes in Patients Receiving Mavacamten and Other Treatments for Symptomatic Obstructive Hypertrophic Cardiomyopathy (Obstructive-HCM)
- Harvard (Massachusetts General Hospital), Boston
- Harvard Medical School - Brigham and Women's Hospital (BWH), Boston
Menerima pesertaStudi observasional
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 19 Agu 2026 · NCT05489705LEVEL-2: LEVosimendan to Improve Exercise Limitation in Patients With PH-HFpEF-2
- Tenax Investigational Site, Boston
Menerima pesertaFase 3
Usia 18 hingga 85 · Semua jenis kelamin · Diperbarui 19 Agu 2026 · NCT07288398Alleviant ALLAY-HF Study
- Brigham and Women's Hospital, Boston
- Boston Medical Center, Boston
Menerima peserta
Usia 40 ke atas · Semua jenis kelamin · Diperbarui 14 Agu 2026 · NCT05685303OPtimal Adult Heart Transplant Immunosuppression With MicroRNA Levels
- Tufts Medical Center, Boston
Menerima pesertaStudi observasional
Usia 18 hingga 99 · Semua jenis kelamin · Diperbarui 11 Agu 2026 · NCT06939751Assessment of CCM in HF With Higher Ejection Fraction
- Massachusetts General Hospital, Boston
Menerima peserta
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 6 Agu 2026 · NCT05064709Care Transitions App for Patients With Multiple Chronic Conditions
- Brigham and Women's Hospital, Boston
Menerima pesertaSukarelawan sehat diterima
Usia 55 ke atas · Semua jenis kelamin · Diperbarui 9 Jul 2026 · NCT06051058The STOP-MED CTRCD Trial
- Brigham and Women's Hospital, Boston
Menerima pesertaFase 4
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 7 Jul 2026 · NCT06183437A Study to Learn More About How Safe Finerenone is, When it is Taken for a Longer Time With Standard Treatment, in Children and Young Adults With Heart Failure and Left Ventricular Systolic Dysfunction
- Boston Children's Hospital - Main Campus - Cardiology, Boston
Menerima pesertaFase 3
Hingga usia 18 · Semua jenis kelamin · Diperbarui 29 Jun 2026 · NCT07192952PROACTIVE-HF-2 Trial Heart Failure NYHA Class II and III
- Tufts Medical Center, Boston
- Boston Medical Center Corporation, Boston
Menerima peserta
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 29 Jun 2026 · NCT05934487A Study to Learn More About How Well Finerenone Works, How Safe it is, and How it Moves Into, Through, and Out of the Body Compared to Placebo When Taken With Standard Treatment in Children With Heart Failure and Left Ventricular Systolic Dysfunction
- Boston Children's Hospital - Main Campus - Cardiology, Boston
Menerima pesertaFase 3
6 Months – 17 Years · Semua jenis kelamin · Diperbarui 15 Jun 2026 · NCT07188805Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in Patients With Advancing Heart Failure
- Massachusetts General Hospital, Boston
Menerima peserta
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 10 Jun 2026 · NCT06526195CCM OPEN HF Registry
- Massachusetts General Hospital, Boston
Menerima pesertaStudi observasional
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 23 Apr 2026 · NCT07112924Promoting Well-being and Health in Heart Failure
- Massachusetts General Hospital, Boston
Menerima peserta
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 14 Apr 2026 · NCT04829617The EMPOWER Trial - The Carillon Mitral Contour System® in Treating Heart Failure With FMR
- St Elizabeth's Medical Center, Boston
- Massachusetts General Hospital, Boston
- Beth Israel Deaconess, Boston
Menerima peserta
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 13 Apr 2026 · NCT03142152Sotagliflozin to Slow Kidney Function Decline in Persons With Type 1 Diabetes and Diabetic Kidney Disease
- Joslin Diabetes Center, Boston
Menerima pesertaFase 3
Usia 18 hingga 75 · Semua jenis kelamin · Diperbarui 24 Mar 2026 · NCT06217302Home Hospital for Suddenly Ill Adults
- Brigham and Women's Hospital, Boston
- Brigham and Women's Faulkner Hospital, Boston
Menerima peserta
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 17 Mar 2026 · NCT03524222Diffusion MRI in Heart Failure
- Massachusetts General Hospital, Charlestown
Menerima pesertaFase awal 1Sukarelawan sehat diterima
Usia 18 hingga 85 · Semua jenis kelamin · Diperbarui 24 Des 2025 · NCT02973633A SkeleTal Muscle Recovery Intervention With Dietary Protein in Heart Failure
- Tufts Medical Center, Boston
Menerima peserta
Usia 18 hingga 100 · Semua jenis kelamin · Diperbarui 25 Nov 2025 · NCT05627440Pulmonary Artery Catheter in Cardiogenic Shock Trial
- Tufts Medical Center, Boston
Menerima peserta
Usia 18 hingga 90 · Semua jenis kelamin · Diperbarui 29 Okt 2025 · NCT05485376US Benchmarking Clinical Study
- Massachusetts General Hospital, Boston
- Brigham and Women's Hospital, Boston
- Boston Medical Center, Boston
Menerima pesertaStudi observasionalSukarelawan sehat diterima
Usia 60 ke atas · Semua jenis kelamin · Diperbarui 20 Okt 2025 · NCT07215715Left vs Left Randomized Clinical Trial
- Massachusetts General Hospital, Boston
- Beth Israel Deaconess Medical Center, Boston
Menerima peserta
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 2 Okt 2025 · NCT05650658Dari ClinicalTrials.gov, data diambil 3 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.